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doi:10.1016/j.kjms.2010.05.003Abstract A 27-year-old female with chronic right-side flank pain was diagnosed with renal
epithelioid angiomyolipoma (EAML) extending as a thrombus into the renal vein and vena cava.
Intravascular extension of EAML is quite rare; however, it may result in fatal complications if
not appropriately treated. She successfully underwent a radical nephrectomy and inferior vena
caval thrombectomy. Intravascular extension of EAML, although rare, has been reported. We
present a new case and a description of the surgical management. Furthermore, we reviewed
and analyzed nine case reports of invasive renal EAMLs.
摘要 患者，女性，27歲，以右側慢性腰痛為主要症狀，在我院診斷為腎上皮樣血管平滑肌脂肪
瘤併發腎靜脈和腔靜脈癌栓。血管侵犯的腎上皮樣血管平滑肌脂肪瘤（EAML）非常罕見，如不
正確治療可出现致命併發症。該患者成功接受腎臓根治性切除及下腔靜脈切開癌栓取出術。盡管
侵犯血管的腎上皮樣血管平滑肌脂肪瘤（EAML）非常少見，但曾被報導。我們描述了一例新病
例及其手術處理方式。此外，我們回顧文獻併分析了至今全球曾報導的9例腎上皮樣血管平滑肌
脂肪瘤併發下腔靜脈癌栓的病例。
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.Introduction
Angiomyolipomas (AMLs) are considered benign renal
tumors, characterized by vascular, smooth muscle, and
mature adipose elements. The components of AML are
thought to arise from unsuppressed and aberrantof Urology, West China Hospital,
com (Q. Dong).
vier Taiwan LLC. All rights reserdifferentiation of the renal mesenchyma [1,2]. However,
cases of epithelioid AML (EAML) involving the renal vein or
inferior vena cava have been rarely reported [1,3e8] and
we have recently experienced a case of right renal EAML
with tumor thrombus into the renal and the inferior vena
cava, which was successfully surgically removed.Sichuan University, Chengdu, Sichuan 610041, China.
ved.
Figure 2. A well-circumscribed 3 4 4 cm mass with
central necrosis (arrow), the hemorrhagic yellow tumor mass in
the upper portion of the kidney infiltrating through the capsule
into the perirenal adipose tissue.
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A 27-year-old female with chronic right-side flank pain had
normal routine laboratory data. Computerized tomog-
raphy (CT) revealed a large heterogeneous upper pole
mass of the right kidney with tumor thrombus in the ipsi-
lateral renal vein extending into the vena cava (Fig. 1).
There was no suggestion of a fatty component to the tumor
on radiographic evaluation, and chest X-ray and CT were
negative. All findings were diagnostic of right renal tumor
associated with right renal vein and inferior vena caval
invasion. Postoperative pathological evaluation revealed
EAML. The patient underwent right radical nephrectomy
and thrombectomy without tumor spillage or complication
and was discharged home after an uneventful
convalescence.
Specimen (Fig. 2) contained a well-circumscribed
3 4 4 cm mass with central necrosis. Gross examination
revealed a hemorrhagic yellow tumor mass in the upper
portion of the kidney infiltrating through the capsule into
the perirenal adipose tissue. All surgical margins, including
ureteral and vascular margins, were free of tumor.
Immunohistochemistry (Fig. 3) showed human melanoma
black 45dHMB 45d(positive), a smoothmuscle actindSMAd
(positive), caldesmon (positive), and desmin (negative).
Discussion
AML is a benign renal lesion composed of thick-walled blood
vessels, smooth muscle cells, and adipose tissue. The inci-
dence has been found to be 0.1% of males and 0.2% of
females in a population without tuberous sclerosis [9]. But
EAML is considered to be a potentially malignant neoplasm
because approximately one-third of cases have been
reported to develop metastatic lesions [10].
To the best of our knowledge, there are only nine cases
of epithelioid AML reported as presenting with involvement
of the renal vein or inferior vena cava [1,3e8]. The dataFigure 1. Contrast-enhanced computed tomography demon-
strates lesion with low density in the level of the upper pole of
right kidney. Tumor thrombus is seen in renal vein and inferior
vena cava (arrow).from these cases relating to each patient’s age and sex,
presenting symptoms, tumor size and location, immuno-
histochemistry, treatment, and follow-up are presented in
Table 1. The present case is included in the summary data,
comprising nine cases in the table. Of the nine patients,
five (55.56%) were male and four (44.44%) were female. The
ages of the patients ranged from 27 to 69 years with a mean
of 44.1 years. Information regarding the locations of the
tumors was not available in one case. Four of the nine
(44.44%) tumors arose from the right side; two (22.22%)
tumors were from the left side, whereas two (22.22%)
tumors appeared on both sides. Seven (77.78%) cases pre-
sented with symptoms and three (33.33%) patients did not
have any symptoms and were diagnosed incidentally on
routine medical checkup. Five of the nine (55.56%) patients
presented with ipsilateral flank pain, two (22.22%) patients
presented with an abdominal mass, and two (22.22%)
patients presented with no symptoms. The average diam-
eter of the tumors in available data was 11.19 cm. In two
(22.22%) cases, the tumors were found to occupy the mid of
kidneys, and in one (11.11%) cases they were found in the
lower pole, whereas in the other six cases, the tumors
extended into the entire kidney. The immunohistochem-
istry of all the cases are positive to HMB-45. From the follow
up information, five (55.56%) are still alive without any
complications, two (22.22%) died during the operation or
postoperative period, whereas one has distant metastasis.
The EAML has been associated with aggressive clinical
behavior, including extension into the vena cava and
metastasis. Islam et al. [5] found that the large size and the
central right side location of the tumor may be contributing
factors of AMLs involving the renal vein or inferior vena
cava. Based on our data, we can get a similar result in
EAML. The shorter and straighter course of the right renal
vein may contribute to the high frequent occurrence of
tumors involving the vena cava. Additionally, the large size
and multifocal tumors imply that the tumors are easily
involved in the major veins. However, the mechanism of
determining why some of the AMLs of the kidney involve the
Figure 3. (A) Tumor cells show strong immunoreaction with antibody to HMB-45 (human melanoma black) (200); (B) Tumor cells
show strong immunoreaction with antibody to SMA (smooth muscle actin) (200); (C) Tumor cells show moderately nuclear atypism
(HE200); (D) Tumor cells show immunoreaction with antibody to caldesmon (200). HEZ hematoxylin-eosin stain.
74 D. Luo et al.renal vein or inferior vena cava is not identified. Islam et al.
[5] once speculated the structures of the tumor vessels in
AML were fragile, which might be related to the develop-
ment of intravenous extensions of the tumor. Additionally,
we speculated that the constituent of epithelioid cell can
be contributed to this aggressive behavior. More data is
needed to verify the mechanism of metastasis. Entirely
benign AMLs may even have alarming clinical properties,
such as invasion of the vena cava or involvement of regional
lymph nodes [11]. Nevertheless, a great majority of such
patients follow a benign clinical course. From the summary
data, six (66.67%) cases were still alive when followed up.
Therefore, based on clinical outcome, this disease has been
considered a multicentric benign disease and not evident of
malignancy in most cases [12]. But its behavior of invasive
growth and insidious fatal complication can be considered
diagnostic of potential malignancy.
There has been skepticism of this diagnosis. In many of
the purported cases of malignant AML, the fat cells and
abnormal blood vessels characteristic of the classic AML
were absent. We were not able to find any reports of EAML
with fat densities noted on CT or magnetic resonance
imaging. The diagnosis of EAML, especially to discriminate
between EAML and renal cell carcinoma (RCC), is occa-
sionally difficult even through imaging studies or histo-
pathological examination. Tumors composed of epithelioid
cells containing a capillary network with a solid growth
pattern are similar to high-grade RCC [13]. Some previously
reported RCC cases associated with tuberous sclerosis have
been thought to be malignant EAML cases [14]. The diag-
nosis can be established by identifying epithelioid cellswithin the tumor and testing of immunohistochemistry
staining for melanoma markers, such as HMB-45 and melan-
A, and smooth muscle cell markers, such as SMA and
caldesmon. The recognition that EAML are uniformly posi-
tive for melanoma markers, such as HMB-45 and melan-A
has facilitated proper diagnosis [14]. The outcome of
immunohistochemistry of all cases in our data are positive
to HMB-45. In some cases proposed as malignant AMLs,
immunoreactivity for HMB-45 are negative. Al-Saleem et al.
[15] once found that some EAML was negative for HMB-45 in
the epithelioid foci, although an adjacent classic focus
showed positive immunoreactivity for this antigen. These
tumors may also be focally positive for smooth muscle
markers, such as SMA [8]. The tumor subsequently restud-
ied by Ferry et al. [16] was positive for desmin, and
immunoreactivity for HMB-45 was ambiguous.
Accurate diagnosis allows for proper selection of
reasonable therapies. Partial nephrectomy or angiographic
embolization has been recommended for symptomatic AML
and AML lesser or greater than 4 cm [17,18]. There is no
evidence to recommend more aggressive surgical manage-
ment for renal lesions, but usually patients were found with
a tumor that extended into the whole kidney with vena
cava involvement and needed radical nephrectomy. Eight
(88.89%) of nine cases underwent radical nephrectomy and
thrombectomy, and only one case accepted the treatment
of partial nephrectomy. Patients with metastatic EAML are
considered chemosensitive. EAML have been reported to
respond to doxorubicin [10]. In other reports, systemic
treatments have included dacarbazine, ifosfamide, and
cisplastin [16,19].
T
a
b
le
1
R
e
p
o
rt
e
d
ca
se
s
o
f
e
p
it
h
e
li
o
id
a
n
gi
o
m
yo
li
p
o
m
a
o
f
ki
d
n
e
y
w
it
h
tu
m
o
r
th
ro
m
b
u
s
in
to
re
n
a
l
ve
in
a
n
d
in
fe
ri
o
r
ve
n
a
ca
va
C
a
se
F
o
ll
o
w
-u
p
T
h
e
ra
p
y
Im
m
u
n
o
h
is
to
ch
e
m
is
tr
yd
H
M
B
,
SM
A
,
a
n
d
d
e
sm
in
Lo
ca
ti
o
n
o
f
tu
m
o
r
Tu
m
o
r
si
ze
(c
m
)
Sy
m
p
to
m
s
Si
d
e
A
ge
(y
r)
/s
e
x
R
e
fe
re
n
ce
1
8
m
o
re
cu
rr
e
n
ce
N
e
p
h
re
ct
o
m
y
þ
þ

M
id
p
a
rt
o
f
th
e
ki
d
n
e
y
6
A
b
d
o
m
in
a
l
p
a
in
Le
ft
60
/M
M
a
rt
ig
n
o
n
i
e
t
a
l.
[8
]
2
D
ie
d
d
u
ri
n
g
o
p
e
ra
ti
o
n
D
ie
d
d
u
ri
n
g
n
e
p
h
re
ct
o
m
y
þ
M
u
lt
if
o
ca
l
12
M
a
ss
B
il
a
te
ra
l
40
/F
K
a
w
a
gu
ch
i
e
t
a
l.
[3
]
3
24
m
o
P
a
rt
ia
l
n
e
p
h
re
ct
o
m
y
þ
M
id
p
a
rt
o
f
th
e
ki
d
n
e
y
4
A
b
d
o
m
in
a
l
p
a
in
Le
ft
61
/M
C
h
a
n
d
ra
so
m
a
e
t
a
l.
[4
]
4
24
m
o
N
e
p
h
re
ct
o
m
y
þ
In
fe
ri
o
r
p
o
le
17
.5
F
la
n
k
p
a
in
h
e
m
a
tu
ri
a
R
ig
h
t
20
/M
C
h
a
n
d
ra
so
m
a
e
t
a
l.
[4
]
5
36
m
o
N
e
p
h
re
ct
o
m
y,
th
ro
m
b
e
ct
o
m
y
þ
W
h
o
le
ki
d
n
e
y
11
N
o
R
ig
h
t
40
/F
Is
la
m
e
t
a
l.
[5
]
6
8
m
o
re
cu
rr
e
n
ce
N
e
p
h
re
ct
o
m
y
þ
þ
W
h
o
le
ki
d
n
e
y
13
N
o
R
ig
h
t
69
/M
P
a
rk
e
t
a
l.
[1
]
7
24
m
o
d
ie
d
N
e
p
h
re
ct
o
m
y
þ
þ
W
h
o
le
ki
d
n
e
y
20
A
b
d
o
m
in
a
l
fu
ll
n
e
ss
B
il
a
te
ra
l
36
/M
Sa
to
e
t
a
l.
[6
]
8
N
e
p
h
re
ct
o
m
y,
th
ro
m
b
e
ct
o
m
y
W
h
o
le
ki
d
n
e
y
A
b
d
o
m
in
a
l
p
a
in
44
/F
M
o
u
d
o
u
n
i
e
t
a
l.
[7
]
9
2
m
o
N
e
p
h
re
ct
o
m
y,
th
ro
m
b
e
ct
o
m
y
þ
þ

W
h
o
le
ki
d
n
e
y
4
A
b
d
o
m
in
a
l
p
a
in
R
ig
h
t
27
/F
Lu
o
e
t
a
l.
[2
0]
F
=
fe
m
a
le
;
H
M
B
Z
h
u
m
an
m
e
la
n
o
m
a
b
la
ck
;
M
=
m
a
le
;
SM
A
Z
sm
o
o
th
m
u
sc
le
a
ct
in
;
þ
Z
p
o
si
ti
ve
;

Z
n
e
ga
ti
ve
.
Epithelioid angiomyolipoma: malignant 75References
[1] Park HK, Zhang S, Wong MK, Kim HL. Clinical presentation of
epithelioid angiomyolipoma. Int J Urol 2007;14:21e5.
[2] Price Jr EG, Mostofi FK. Symptomatic angiomyolipoma of the
kidney. Cancer 1965;18:761e74.
[3] Kawaguchi K, Oda Y, Nakanishi K, Saito T, Tamiya S, Nakahara K,
et al.Malignant transformationof renal angiomyolipoma:acase
report. Am J Surg Pathol 2002 Apr;26:523e9.
[4] Chandrasoma S, Moatamed N, Chang A, Daneshmand S,
Ma Y. Angiomyolipoma of the kidney: expanding disease
spectrum demonstrated by 3 cases. Appl Immunohistochem
Mol Morphol 2004;12:277e83.
[5] Islam AH, Ehara T, Kato H, Hayama M, Kashiwabara T,
Nishizawa O. Angiomyolipoma of kidney involving the infe-
rior vena cava. Int J Urol 2004;11:897e902.
[6] Sato K, Ueda Y, Tachibana H, Miyazawa K, Chikazawa I, Kaji S,
et al. Malignant epithelioid angiomyolipoma of the kidney in
a patient with tuberous sclerosis: an autopsy case report with
p53 gene mutation analysis. Pathol Res Pract 2008;204:771e7.
[7] Moudouni SM, Tligui M, Sibony M, Doublet JD, Haab F,
Gattegno B, et al. Malignant epithelioid renal angiomyoli-
poma involving the inferior vena cava in a patient with
tuberous sclerosis. Urol Int 2008;80:102e4.
[8] Martignoni G, Pea M, Bonetti F, Zamboni G, Carbonara C,
Longa L, et al. Carcinomalike monotypic epithelioid angio-
myolipoma in patients without evidence of tuberous sclerosis:
a clinicopathologic and genetic study. Am J Surg Pathol 1998;
22:663e72.
[9] Fujii Y, Ajima J, Oka K, Tosaka A, Takehara Y. Benign renal
tumors detected among healthy adults by abdominal ultraso-
nography. Eur Urol 1995;27:124e7.
[10] Cibas ES, Goss GA, Kulke MH, Demetri GD, Fletcher CD.
Malignant epithelioid angiomyolipoma (“sarcomaex angio-
myolipoma”) of the kidney: a case report and review of the
literature. Am J Surg Pathol 2001;25:121e6.
[11] Cittadini Jr G, Pozzi Mucelli F, Danza FM, Derchi LE, Pozzi
Mucelli RS. “Aggressive” renal angiomyolipoma. Acta Radio-
logica 1996;37:927e32.
[12] Tsui WM, Colombari R, Portmann BC, Bonetti F, Thung SN,
Ferrell LD, et al. Hepatic angiomyolipoma: a clinicopathologic
study of 30 cases and delineation of unusual morphologic
variants. Am J Surg Pathol 1999;23:34e48.
[13] Pea M, Bonetti F, Martignoni G, Henske EP, Manfrin E,
Colato C, et al. Apparent renal cell carcinomas in tuberous
sclerosis are heterogeneous: the identification of malignant
epithelioid angiomyolipoma. Am J Surg Pathol 1998;22:180e7.
[14] PeaM, Bonetti F, ZamboniG,Martignoni G, RivaM, Colombari R,
et al. Melanocyte-marker-HMB-45 is regularly expressed in
angiomyolipoma of the kidney. Pathology 1991;23:185e8.
[15] Al-Saleem T, Wessner LL, Scheithauer BW, Patterson K,
Roach ES, Dreyer SJ, et al. Malignant tumors of the kidney,
brain and soft tissues in children and young adults with the
tuberous sclerosis complex. Cancer 1998;83:2208e16.
[16] Ferry JA, Malt RA, Young RH. Renal angiomyolipoma with
sarcomatous transformation and pulmonary metastases. Am J
Surg Pathol 1991;15:1083e8.
[17] Oesterling JE, Fishman EK, Goldman SM, Marshall F. The
management of renal angiomyolipoma. JUrol 1986;135:1121e4.
[18] Steiner MS, Goldman SM, Fishman EK, Marshall FF. The natural
history of renal angiomyolipoma. J Urol 1993;150:1782e6.
[19] LoweBA,Brewer J,HoughtonDC, JacobsonE, PitreT.Malignant
transformation of angiomyolipoma. J Urol 1992;147:1356e8.
[20] Luo D, Gou J, Yang L, Xu Y, Dong Q. Epithelioid angiomyoli-
poma with involvement of inferior vena cava as a tumor
thrombus: a case report. Kaoh J Med Sci 2011, doi:
1016/j.kjms.2010.05.003
